PDE5 Enzyme Deficiency and Back Pain: No Established Association
There is no evidence that a deficiency of phosphodiesterase-5 (PDE5) enzyme causes back pain. In fact, the relationship is reversed: PDE5 inhibition (not deficiency) is associated with back pain as a known adverse effect of PDE5 inhibitor medications.
The Actual Relationship: PDE5 Inhibitors Cause Back Pain
PDE5 inhibitors (sildenafil, tadalafil, vardenafil, avanafil) are medications used primarily for erectile dysfunction that block PDE5 enzyme activity. Back pain and myalgia are recognized adverse effects of these drugs 1, 2.
Key Evidence on PDE5 Inhibitor-Related Back Pain:
- Incidence: Back pain and/or myalgia occurs in 8-9% of patients taking tadalafil (10-20 mg) compared to 3.7% with placebo 2
- Mechanism: The exact mechanism remains unknown, but these events appear to be self-limiting and represent a general effect of PDE5 inhibition 2
- Clinical significance: Most cases are mild; only 0.3-0.7% of patients discontinue treatment due to back pain 2
- Common adverse effects: Back pain is listed alongside headache, flushing, dyspepsia, myalgia, and nasal congestion as frequent side effects 1, 3, 4
Important Clinical Context:
The question appears to conflate two unrelated concepts:
- PDE5 enzyme deficiency (a theoretical state with no documented clinical syndrome)
- Back pain as a symptom (a common musculoskeletal complaint)
No medical literature supports PDE5 enzyme deficiency as a cause of back pain. The comprehensive low back pain guidelines from the American College of Physicians and British Pain Society 5, 6 make no mention of PDE5 enzyme levels or deficiency in the evaluation or pathophysiology of back pain.
Management of Back Pain Remains Standard
For patients with back pain—regardless of PDE5 inhibitor use—follow evidence-based guidelines 6:
- First-line: Acetaminophen or NSAIDs with patient education to remain active
- Non-pharmacologic options: Exercise therapy, spinal manipulation, physical therapy, acupuncture for chronic pain
- Evaluation: Focus on red flags (cancer, infection, cauda equina syndrome) rather than enzyme deficiencies
If a patient develops back pain while taking PDE5 inhibitors, this represents a known drug side effect rather than an underlying enzyme deficiency requiring correction.